1998
DOI: 10.1074/jbc.273.28.17756
|View full text |Cite
|
Sign up to set email alerts
|

Cloning and Characterization of a Novel Binding Factor (GMEB-2) of the Glucocorticoid Modulatory Element

Abstract: The 21-base pair glucocorticoid modulatory element (GME) of the rat tyrosine aminotransferase gene is the only cis-acting element known to modulate the transcriptional activity of receptors bound to glucocorticoid response elements. Specifically, the GME increases the activity of complexes bound both by physiological concentrations of glucocorticoids, due to a left shift in the dose-response curve, and by saturating concentrations of anti-glucocorticoids. For this reason, the nuclear protein(s) that has been d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
43
0

Year Published

2001
2001
2010
2010

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(45 citation statements)
references
References 45 publications
(77 reference statements)
2
43
0
Order By: Relevance
“…The GME is part of the upstream enhancer region of the endogenous TAT gene and its effects with GR appear to be mediated by two proteins, GMEB-1 and -2, that bind to the GME as a heterooligomer (Oshima et al, 1995). The presence of the GME in other genes is, unfortunately, difficult to predict due to the frequency with which the four base binding sequence occurs (Oshima et al, 1995;Zeng et al, 1998), usually as a tandem repeat with a flexible spacing of from 1 to as much as 15 bp (Christensen et al, 1999). Therefore, the frequency with which the GME occurs in other regulated genes to afford possible differences between PR-and GR-mediated induction is currently unknown.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…The GME is part of the upstream enhancer region of the endogenous TAT gene and its effects with GR appear to be mediated by two proteins, GMEB-1 and -2, that bind to the GME as a heterooligomer (Oshima et al, 1995). The presence of the GME in other genes is, unfortunately, difficult to predict due to the frequency with which the four base binding sequence occurs (Oshima et al, 1995;Zeng et al, 1998), usually as a tandem repeat with a flexible spacing of from 1 to as much as 15 bp (Christensen et al, 1999). Therefore, the frequency with which the GME occurs in other regulated genes to afford possible differences between PR-and GR-mediated induction is currently unknown.…”
Section: Discussionmentioning
confidence: 99%
“…2C, 0.44 ± 0.10 fold left-shift, n=4, P = 0.011), the partial agonist activity of Dex-Mes decreases by 46 ± 3% (n = 4, P=0.0008), while the V max of PR-mediated transactivation is further reduced by 77 ± 5% (n = 4, P = 0.0005). Thus, even though the presence of the GME in the regulated reporter construct does not alter PR induction properties, overexpression of GMEB-2, which binds to the GME sequence (Oshima et al, 1995;Zeng et al, 1998) and to GR (Kaul et al, 2000), exerts effects that are GMEB-2 dose-dependent. In summary, two transactivation properties of PR and GR (i.e., EC 50 and partial agonist activity of antisteroids) respond equally to high GMEB-2 concentrations but in opposite manners to low GMEB-2 while the response of V max with each receptor is the same.…”
Section: Influence Of Gmeb-2 On Gr Vs Pr Transactivationmentioning
confidence: 99%
See 2 more Smart Citations
“…Hnf1 and its transcriptional coactivator, Dcoh, are also involved in the regulation of a number of other genes including some acute-phase inflammatory response genes described above (7,14). Two of the upregulated transcription factors are known to be involved in downregulation of immune and inflammatory responses: nuclease-sensitive element binding protein (Nsep1) represses HLA class II gene expression (65), and glucocorticoid modulatory element binding protein 2 (Gmeb2) modulates transcriptional activity of the glucocorticoid receptor (73). Thus, these transcription factors may mediate immune modulatory effects of ciprofibrate.…”
Section: Rnas Ten Different Control Rnas (C1-c10)mentioning
confidence: 99%